Table 1.

Other clinical manifestations at initial diagnosis of chronic graft-versus-host disease (GVHD) and ever noted, based on 324 patients diagnosed with chronic GVHD according to NIH consensus criteria, transplanted at FHCRC 2003–2005.(M. Flowers, unpublished data)

At onset, %Ever, %
Sites involved 
    Skin 74 81 
    Finger/toenail/mouth 19 
    Mouth 87 89 
    Eyes 34 47 
    G.I. tract 40 48 
    Esophagus 
    Liver 35 47 
    Vagina/penis 10 
    Lungs 14 
    Joints 15 
    Muscle 
    Serosa 
    Myofascial 16 
Clinical manifestations/complications 
    Weight loss 22 31 
    Joint contracture 
    Malabsorption <1 
    Keratoconjunctivitis 
    Cutaneous sclerosis 13 
    Esophageal stricture <1 
    Bronchiolitis obliterans syndrome <1 
    Eosinophilia 14 20 
    Bronchiolitis obliterans organizing pneumonia 
Other characteristics 
    Progressive onset 13  
    Quiescent onset 60  
    De novo onset 27  
    On steroids at diagnosis 34  
    Platelets < 100,000 at diagnosis 31  
At onset, %Ever, %
Sites involved 
    Skin 74 81 
    Finger/toenail/mouth 19 
    Mouth 87 89 
    Eyes 34 47 
    G.I. tract 40 48 
    Esophagus 
    Liver 35 47 
    Vagina/penis 10 
    Lungs 14 
    Joints 15 
    Muscle 
    Serosa 
    Myofascial 16 
Clinical manifestations/complications 
    Weight loss 22 31 
    Joint contracture 
    Malabsorption <1 
    Keratoconjunctivitis 
    Cutaneous sclerosis 13 
    Esophageal stricture <1 
    Bronchiolitis obliterans syndrome <1 
    Eosinophilia 14 20 
    Bronchiolitis obliterans organizing pneumonia 
Other characteristics 
    Progressive onset 13  
    Quiescent onset 60  
    De novo onset 27  
    On steroids at diagnosis 34  
    Platelets < 100,000 at diagnosis 31